AstraZeneca Launches Eculizumab in India – First Approved Anti-Complement Therapy for Rare Blood and Kidney Disorders

By Team VOH

AstraZeneca India has introduced its C5 inhibitor, Eculizumab, marking a significant step in the treatment of rare

Read more